Is there a link between pharmaceutical consumption and improved health in OECD countries?

PharmacoEconomics

Volumn 18, Issue SUPPL. 1, 2000, Pages 33-45

  Miller, R D J ^a   Frech, H E I ^b  

^a CNA CORPORATION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

AGE; CONFERENCE PAPER; DEVELOPED COUNTRY; DRUG COST; DRUG USE; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; INFANT MORTALITY; INTERNATIONAL COOPERATION; LIFE EXPECTANCY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL;

EID: 0033765019     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200018001-00006     Document Type: Conference Paper

References (18)

1. The productivity of health care and pharmaceuticals: An international comparison
2. Allocations of resources to health
3. The production of health, an exploratory study
4. The political and economic determinants of health outcomes: A cross-national analysis
5. International comparative analysis: Main findings and conclusions
6. Medicare spending and mortality rates of the elderly
7. Is there a Sisyphus syndrome in healthcare?
8. A comparison of international health outcomes and healthcare spending
9. Regulation and health: The case of mandatory prescriptions and an extension
10. The effect of pharmaceutical utilisation and innovation on hospitalization and mortality
11. The costs and benefits of intensive treatment for cardiovascular disease
12. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes
13. Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenial
14. International comparison of drug consumption: Impact of prices
15. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction